Podcasts about fccp

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:Why early detection is key for improving patient outcomesHow to monitor through use of noninvasive imaging and biopsy per guideline recommendationsHow to coordinate patient care to provide much-needed multidisciplinary careWhat therapies in the pipeline could transform the treatment landscape for this genetic disease PresentersPaula Henao, MDAssistant Professor of MedicineDivision of Pulmonary, Allergy and Critical Care MedicinePenn State Hershey Medical CenterHershey, PennsylvaniaRohit Loomba, MD, MHScProfessor of MedicineChief, Division of Gastroenterology and HepatologyDirector, MASLD Research CenterUniversity of California, San DiegoSan Diego, CaliforniaCheryl Pirozzi, MD, MSAssociate Professor of Internal MedicineDivision of Pulmonary and Critical Care MedicineUniversity of UtahSalt Lake City, UtahCorinne Young, NP, FCCPPresident/FounderAssociation of Pulmonary Advanced Practice ProvidersColorado Springs, ColoradoLink to full program: https://bit.ly/4dgCRnq

CHEST May 2025, Volume 167, Issue 5  CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST May 2025 issue, including an exploration into associations between socioeconomic status and frailty in patients with COPD, trends in all-cause mortality among US veterans with sarcoidosis, and much more. 

It's The Ranch It Up Radio Show! Join me Jeff Tigger Erhardt, Rebecca Wanner AKA BEC and my crew as we hear how Angus, Red Angus, Smokey and Buff colored calves all can receive the same premium.  Plus news, markets and a whole lot of the cow stuff that you will only get on this all new episode of The Ranch It Up Radio Show.  Be sure to subscribe on your favorite podcasting app or on the Ranch It Up Radio Show YouTube Channel.   Season 5, EPISODE 231 Sustainable Beef: A Processing Plant Where Color Doesn't Matter New Beef Processing Plant With Competitive Fed Cattle Grid Premiums The Red Angus Association of America (RAAA) recently showcased an innovative fed cattle grid pricing system at the NCBA Trade Show. This system, adopted by Sustainable Beef LLC, is set to transform the industry by offering competitive premiums for upper two-thirds Choice carcasses, regardless of hide color. Angus, Red Angus & Charolais Cross Cattle Receive Same Premium Tom Brink, RAAA CEO, announced that Sustainable Beef LLC, opening in April 2025 in North Platte, Nebraska, will implement a color-blind grid system, equally rewarding Red Angus, Black Angus, and smoky cattle. “This system levels the feeder calf market, allowing feedlots to confidently invest in Red Angus and black-hided cattle, knowing both will qualify for top premiums,” Brink said. Kelly Smith, RAAA Director of Commercial Marketing, emphasized RAAA's efforts to connect Red Angus producers with feedlots through its feeder cattle network. He highlighted that FCCP-tagged cattle will meet the Angus label's genetic verification standards, ensuring seamless access to premium marketing opportunities. Mark Nelson, Sustainable Beef's Director of Cattle Procurement, reinforced the company's commitment to sustainability and producer profitability. Sustainable Beef will provide an exceptional work environment and favor moderate carcass sizes, which naturally benefits Red Angus genetics. The RAAA-Sustainable Beef collaboration represents a significant step forward in ensuring equitable market opportunities for all quality cattle. This initiative will drive profitability for producers while delivering high-quality beef to consumers. For more details, visit RedAngus.org. Cattle Industry News JBS Sees Strong Demand Despite Challenges In The U.S. Cattle Cycle According to JBS executives, JBS expects a more challenging US cattle supply scenario in 2025 compared to last year, when strong beef consumption and initiatives to improve commercial and operational efficiencies contributed to the performance of the US beef business unit. Executives commented saying that the U.S. cattle cycle will likely be more challenging this year, regardless of the speed of herd replacement, specifically saying that JBS Beef North America's margins still have room to improve by 1% to 1.5% in 2025 due to the company's initiatives to improve commercial and operational efficiencies. Robust demand continues to support the company's investments in expanding its US meat processing and prepared food facilities. In February, JBS announced $200 million in investments to expand its beef production facilities in Cactus, Texas, and Greeley, Colo. In the other regions where JBS operates, demand for all animal proteins also remains strong. RanchChannel.Com Now Has The Futures Markets & New Listings Futures Markets RanchChannel.com now has futures markets at your fingertips!  Feeder Cattle, Live Cattle, Corn, Wheat, Soybeans, Soybean Oil, Milk Class IV, and Ethanol.  Information is provided by DTN and market information may be delayed by as much as 10 minutes.  Click Here for more information! UPCOMING SALES & EVENTS Heartland Cattle Co.:  April 7, 2025 DLCC Ranch: April 19, 2025 Jorgensen Land & Cattle:  April 21, 2025 Wilson Angus: April 28, 2025 World Famous Miles City Bucking Horse Sale: May 15 - 18, 2025 BULL SALE REPORT & RESULTS Click HERE for the latest Bull Sale Results https://ranchchannel.com/category/past-bull-production-sales-archive/ FEATURING Tom Brink Red Angus Association of America https://redangus.org/ https://www.facebook.com/RedAngusAssociationOfAmerica   Mark Vanzee Livestock Market, Equine Market, Auction Time https://www.auctiontime.com/ https://www.livestockmarket.com/ https://www.equinemarket.com/ @LivestockMkt @EquineMkt @AuctionTime   Kirk Donsbach: Stone X Financial https://www.stonex.com/   @StoneXGroupInc      Shaye Koester Casual Cattle Conversation https://www.casualcattleconversations.com/ @cattleconvos   Questions & Concerns From The Field? Call or Text your questions, or comments to 707-RANCH20 or 707-726-2420 Or email RanchItUpShow@gmail.com FOLLOW Facebook/Instagram: @RanchItUpShow SUBSCRIBE to the Ranch It Up YouTube Channel: @ranchitup Website: RanchItUpShow.com https://ranchitupshow.com/ The Ranch It Up Podcast is available on ALL podcasting apps. https://ranchitup.podbean.com/ Rural America is center-stage on this outfit. AND how is that? Tigger & BEC Live This Western American Lifestyle. Tigger & BEC represent the Working Ranch world and cattle industry by providing the cowboys, cowgirls, beef cattle producers & successful farmers the knowledge and education needed to bring high-quality beef & meat to your table for dinner. Learn more about Jeff 'Tigger' Erhardt & Rebecca Wanner aka BEC here: TiggerandBEC.com https://tiggerandbec.com/   #RanchItUp #StayRanchy #TiggerApproved #tiggerandbec #rodeo #ranching #farming References https://www.stonex.com/ https://www.livestockmarket.com/ https://www.equinemarket.com/ https://www.auctiontime.com/ https://gelbvieh.org/ https://www.imogeneingredients.com/ https://alliedgeneticresources.com/ https://westwayfeed.com/ https://medoraboot.com/ https://www.tsln.com/ https://transova.com/ https://axiota.com/ https://axiota.com/multimin-90-product-label/ https://jorgensenfarms.com/ https://ranchchannel.com/ https://www.wrangler.com/ https://www.ruralradio147.com/ https://www.rfdtv.com/ https://www.wulfcattle.com/#/?ranchchannel=view https://www.cattlebusinessweekly.com/articles/new-fed-cattle-grid-for-red-angus/ https://hpj.com/2025/03/06/red-angus-members-host-grid-pricing-update/ https://www.meatingplace.com/Industry/News/Details/118479

Asad E. Patanwala, PharmD, MPH, and Brian L. Erstad, PharmD, join CHEST Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss their research into the effect of albumin administration on the need for renal replacement therapy and mortality in patients with septic shock and renal impairment. DOI: 10.1016/j.chest.2024.10.012 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Judith Maria Brock, MD, joins CHEST Journal Podcast Moderator Alice Gallo De Moraes, MD, FCCP, to discuss her research into the differences in severity grades of pneumothorax and their effect on clinical practice.   DOI: 10.1016/j.chest.2024.10.045 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST April 2025, Volume 167, Issue 4 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST April 2025 issue, including a new guideline on alpha-1-antitrypsin deficiency targeted testing and augmentation therapy, a review of conflict of interest disclosure in bronchoscopy research, and an exploration into the growth of screening-detected pure ground-glass nodules after 10 years of stability.  Moderator: Peter Mazzone, MD, MPH, FCCP

Listen in as our expert panel discusses which diabetes meds have cardiovascular (CV) benefits.  We'll review the evidence and discuss the pros and cons of SGLT2 inhibitors (dapagliflozin, empagliflozin, etc) and GLP-1 agonists (dulaglutide, semaglutide, etc) in patients with or at risk for CV disease.Special Guests:Lauren G. Pamulapati, PharmD, BCACPAssociate Professor, Ambulatory CareVirginia Commonwealth University School of PharmacyClinical Pharmacist, Hayes Willis Health Center/VCU HealthChristie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCPProfessor, Pharmacy PracticeDirector, PGY2 Ambulatory Care Residency ProgramMidwestern University College of Pharmacy, Downers Grove CampusClinical Pharmacist, Northwestern MedicineTRC Editorial Advisory Board Participant:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleFor the purposes of disclosure, Dr. Schumacher reports a relevant financial relationship [CGM for diabetes management] with Abbott (speakers bureau).The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in February 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Diabetes Medications: Cardiovascular and Kidney ImpactChart: Drugs for Type 2 Diabetes Algorithm: Stepwise Treatment of Type 2 DiabetesChart: Comparison of GLP-1 AgonistsToolbox: Improving Heart Failure CareSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

CHEST March 2025, Volume 167, Issue 3 CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST March 2025 issue, including an exploration of the effectiveness of guideline-recommended activities for children with asthma, a review of health system purchasing professionals' approaches to considering equity in procurement, and a new guideline on the acquisition and handling of endobronchial ultrasound transbronchial need samples. Moderator: Peter Mazzone, MD, MPH, FCCP

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-057-H01-PInitial release date: 3/3/2025Expiration date: 3/3/2026Additional CPE details can be found here.

Antibiotic resistance is a growing global crisis, and pharmacists are on the frontlines of combating this threat through effective stewardship practices. This episode explores the latest updates in antimicrobial stewardship and shares actionable strategies to combat resistance and optimize antibiotic use. Tune in to strengthen your role as a steward of antibiotic efficacy and help preserve these life-saving medications for future generations.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTGeoff Wall, PharmD, FCCP, BCPSProfessor of Pharmacy PracticeIowa Methodist Medical CenterPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Explain the impact of antibiotic resistance on public health and the role of antimicrobial stewardship in addressing this crisis.2. Identify evidence-based strategies pharmacists can implement to optimize antibiotic use and combat resistance in their practice settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-057-H01-PInitial release date: 3/3/2025Expiration date: 3/3/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, joined Over the Counter to discuss the 2025 Pharmacy Forecast and challenges within the business behind health-system pharmacies.

In this episode of ACEP Nowcast, host Amy Faith Ho, MD, MPH, FACEP, interviews Rade B. Vukmir, MD, JD, FCCP, FACEP, FACHE, about employment contracts and what to look out for when emergency physicians are reviewing their contracts. Read more on ACEPNow.com Revisit ACEP Nowcast podcast episodes.  Catch up on all of ACEP Now in past issues.

CHEST February 2025, Volume 167, Issue 2 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST February 2025 issue, including a new guideline on RBC transfusion in critically ill adults, research exploring the association between air pollution and lung function in sarcoidosis, and much more.

In this episode, Catherine Chang, MD, MMM, FCCP - Vice President and Chief Quality Officer, Ambulatory and Clinical Councils at Prisma Health, discusses the health system's continued growth, commitment to quality care, and initiatives to enhance access for patients. She also highlights the challenges of managing healthcare resources, provider demand, and integrating AI into clinical operations while evolving as a leader in an ever-changing landscape.

Nathan C. Nowalk, MD, and Babak Mokhlesi, MD, FCCP, join CHEST® Journal Podcast Moderator, Alice De Gallo Moraes, MD, FCCP, to discuss their research into the association between gender and outcomes among hospitalized and ambulatory adults with obesity hypoventilation syndrome. DOI: 10.1016/j.chest.2024.10.002   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Ryota Sato, MD, MPH, FCCP, joins CHEST® Journal Podcast Moderator, Alice De Gallo Moraes, MD, FCCP, to discuss his research into the potential survival benefits associated with the use of ultra-short-acting β-blockers (esmolol or landiolol) in patients with sepsis with persistent tachycardia. DOI: 10.1016/j.chest.2024.08.020   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST January 2025, Volume 167, Issue 1 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST January 2025 issue, including research into understanding nonpharmacologic palliative care for patients with COPD, gender differences in patients with obesity hypoventilation syndrome, and more.  

It's Best-Of Week on The Academic Minute:  In today's segment, C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, discussed a new treatment for those suffering from depression. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; […]

Interviews with Leaders in Clinical Pharmacy: Stuart T. Haines, Pharm.D., FCCP, FAPhA, FASHP, BCACP, BCPS, incoming JACCP Editor-in-Chief

In this episode, host Kathy Schott and guest Andrea Sikora explore the transformative power of artificial intelligence in pharmacy education and clinical teaching. Join us as we discuss the latest trends in AI, practical strategies for integrating these tools into your teaching routine, and the challenges preceptors face in this rapidly evolving field. From selecting the right AI platforms to ensuring students critically evaluate AI-generated insights, we'll provide actionable advice and real-world success stories to inspire innovation in your practice. Whether you're a seasoned preceptor or just beginning your AI journey, this episode is your guide to leveraging technology for better learning and patient care. Tune in and transform the way you teach with AI! HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestAndrea Sikora, PharmD, MSCR, BCCCP, FCCP, FCCMClinical Associate ProfessorUniversity of Georgia College of PharmacyGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Describe how AI is transforming pharmacy practice and its implications for clinical education.2. Discuss methods to balance AI recommendations with traditional clinical decision-making skills.0.05 CEU/0.5 HrUAN: 0107-0000-24-322-H99-PInitial release date: 12/18/2024Expiration date: 12/18/2027Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

In this exciting episode of the Pediatric Pharmacist Review Podcast, we're diving into the fascinating world of pharmacogenomics and its transformative impact on pediatric care. Our special guest is Dr. Kelly E. Caudle, Pharm.D., Ph.D., FCCP, an Associate Member in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children's Research Hospital. Dr. Caudle brings a wealth of expertise to the discussion, with over a decade of experience in pharmacogenomics implementation. As the Director of the NIH-funded Clinical Pharmacogenetics Implementation Consortium (CPIC), she oversees groundbreaking work in translating genetic test results into actionable prescribing decisions. With CPIC publishing 28 gene-based clinical guidelines covering 29 genes and over 150 drugs, Dr. Caudle's leadership is reshaping personalized medicine for children worldwide. Tune in as we explore how pharmacogenomics is enabling tailored treatments for pediatric patients, improving medication efficacy, and minimizing adverse effects. Dr. Caudle also shares insights into her work at St. Jude Children's Research Hospital and offers a glimpse into the future of personalized pediatric care. Key Takeaways: What pharmacogenomics is and why it matters for pediatric medicine. How CPIC guidelines are helping clinicians make data-driven prescribing decisions. The role of genetic testing in improving medication safety and outcomes for children. Dr. Caudle's journey in leading pharmacogenomics research and clinical implementation. Guest Bio: Dr. Kelly E. Caudle is a leading expert in pharmacogenomics, with over 100 publications and abstracts to her name. Her work has advanced the clinical implementation of pharmacogenetics at St. Jude Children's Research Hospital and beyond. As a passionate researcher and educator, she has inspired countless professionals through her national and international presentations.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/MKD865. CME/MOC/AAPA credit will be available until December 19, 2025.Targeting a New Approach in COPD: Understanding the Potential Role of Biologic Therapy in Patients With Evidence of Type 2 Inflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Today we are bringing you insights from 3 separate interviews with experts about the treatment, management, and burdens of idiopathic pulmonary fibrosis (IPF). In this podcast, you'll hear insight from the following individuals: Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine, USC; Martin Kolb, MD, PhD, professor of medicine, McMaster University; and Steven Nathan, MD, FCCP, medical director of the Advanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, and professor of medicine, University of Virginia. These experts discuss what IPF is, how it impacts patients' quality of life, barriers to care, and treatments in the pipeline.

CHEST December 2024, Volume 166, Issue 6 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST December 2024 issue, including research into the impact of dyspnea in adults with respiratory symptoms; differences in health care and palliative cCare utilization at the end of life; and more.

Special guest Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP, Professor and Director of the Community-Based Residency Program at the Virginia Commonwealth University School of Pharmacy, join(s) us to talk about immunizations.Listen in as we discuss the latest COVID-19, influenza, and RSV vaccine recommendations and answer some common questions about giving vaccines.You'll also hear practical advice from TRC Editorial Advisory Board member, Stephen Carek, MD, CAQSM, DipABLM, the Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, Greenville.For the purposes of disclosure, Dr. Goode reports relevant financial relationships [vaccines] with Pfizer, Valneva (honorarium). The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Flu Vaccines for 2024-25 (United States)Chart: COVID-19 Vaccines 2024-25 (United States)FAQ: Preventing RSVResource Hub: Immunization Resource HubIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

2024-11-22 Hosts Craig Lipset, Amir Kalali, and Jane Myles were joined by Keith Robinson, MD, MS, FCCP and Megan Parisi, MS, CCRP from Syneos Health and Nick Delmonico from Strados Labs for a discussion around wearables. We discussed challenges in increasing adoption of wearables, factors that are holding things back from greater widespread adoption, and the benefits/ROI of wearables and novel measurements.You can join TGIF-DTRA Sessions live on LinkedIn Live Audio on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.

CHEST November 2024, Volume 166, Issue 5 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST November 2024 issue, including research into patient and provider perspectives driving inhaler choice, a framework for research gaps in pediatric ventilator liberation, and more.

In this episode of Elevate Care, Dr. Danielle McCamey  discusses the critical role of mentorship in nursing, particularly for nurses of color. She emphasizes the importance of having multiple mentors, each serving different roles in one's career. Dr. McCamey also highlights the mission of DNPs of Color, an organization she founded to support nurses of color through networking, mentorship, and advocacy. The conversation explores strategies for finding mentors, being a good mentee, and creating inclusive environments in nursing.Learn more about the show: https://www.amnhealthcare.com/campaign/elevate-care-podcast/https://www.dnpsofcolor.org/TIMESTAMPS00:00 The Importance of Mentorship in Nursing06:08 Diversity in Nursing and Mentorship09:45 DNPs of Color: Mission and Impact12:58 Finding and Being a Good Mentee18:38 Creating Inclusive Environments in Nursing20:26 Empowering Nurses as LeadersABOUT DR. MCCAMEYDanielle K. McCamey, DNP, CRNP, ACNP-BC, FCCP, is a seasoned critical care clinician and visionary leader committed to advancing inclusion and belonging in nursing. As the founder of DNPs of Color, she established a global platform that empowers nurses of color through networking, mentorship, and advocacy. Her work through DNPs of Color has increased diverse representation in doctoral nursing practice, catalyzing a transformative shift within the profession. McCamey's leadership extends beyond DNPs of Color. As the co-creator of the Doctoral Nurses Collaborative, she united DNP- and PhD-prepared nurses across her healthcare system, providing invaluable mentorship, promoting evidence-based practice, and amplifying nursing scholarship. She is the assistant dean for strategic partnerships at Johns Hopkins School of Nursing, where she leads initiatives to cultivate and fortify relationships with healthcare organizations, educational institutions, and community partners. Her commitment to excellence extends beyond nursing. As a fellow of the American College of Chest Physicians, she earned numerous accolades and was honored as a Distinguished CHEST Educator for her exceptional contributions to education and critical care. Her influence reaches beyond her professional achievements. She is a highly sought-after speaker and mentor, renowned for her inspirational and motivational insights. McCamey's transformative leadership and pioneering spirit continue to advance the nursing professionConnect with Dr. McCamey https://www.linkedin.com/in/mccamey/ABOUT KERRYKerry Perez leads the design and development of enterprise strategy in addition to overseeing Marketing, Corporate Communications, and Creative Services.Ms. Perez joined AMN Healthcare in 2007 and has held various roles during her tenure, including recruitment, marketing, innovation, strategy, and M&A. She most recently served as the company's Vice President of Enterprise Strategy. She also stood up AMN Healthcare's Diligence and Integration Management Office, which led the strategic and functional integration of new acquisitions to drive synergy. She was named among Staffing Industry Analyst's Top 40 Under 40 in 2021, and she hosts the AMN Healthcare podcast, Elevate Care.Ms. Perez maintains the guiding principles of being customer obsessed, thinking big and delivering results. She has a passion for mentoring emerging leaders and building effective teams.Ms. Perez holds a Bachelor of Arts degree in Business Economics and a Bachelor of Arts degree in Communication from the University of California at Santa Barbara. For more than four years, she has served on the board of Dallas-based nonprofit, CitySquare, which focuses on fighting the causes and effects of poverty. Connect with Kerry: https://www.linkedin.com/in/kerrycperez/ FIND US ONWebsite – https://www.amnhealthcare.com/podcast/elevate-care-podcast/YouTube – https://www.youtube.com/@ElevateCarePodcastSpotify – https://open.spotify.com/show/5R2oWLZXYfjtPGW7o5KpuoApple – https://podcasts.apple.com/us/podcast/elevate-care/id1710406359Instagram – https://www.instagram.com/amnhealthcare/LinkedIn – https://www.linkedin.com/company/amn-healthcare/X – https://twitter.com/amnhealthcare/Facebook – https://www.facebook.com/amnhealthcare/ Powered by AMN Healthcare

ONE STORY A DAY / Una historia para cada Día es una iniciativa para celebrar el Mes de la Herencia Hispana 2024 de Hispanic Chamber Cincinnati USA y Latina Today Podcast series. El Dr. Benzaquen, MD, ATSF, FACP, FCCP es el presidente del Departamento de Medicina Pulmonar, Cuidados Intensivos y Medicina del Sueño en Einstein Healthcare Network en Filadelfia. Dr. Benzaquen habla de su vida, su trasfondo cultural y cómo esto lo ha moldeado su vida. Dr. Benzaquen habla sobre su pasión por enseñar a las nuevas generaciones y lo que ha aprendido de su trabajo como médico y de sus pacientes. El Dr. Benzaquen recientemente completo su MBA y comparte un consejo a las personas y a la comunidad latina de Ohio.

CHEST October 2024, Volume 166, Issue 4 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST October 2024 issue, including research into characteristics of adults with severe asthma in childhood, the association of pregnancy with outcomes among critically ill reproductive-aged women, and much more.

Special guest Lori A. Wilken, PharmD, FCCP, BCACP, NCTTP, AE-C, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago, joins us to talkabout Asthma and COPD treatment.Listen in as we discuss answers to your big questions about treatment of asthma and COPD. You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Wilken reports relevant financial relationships [pulmonary] with AstraZeneca/Simpson Healthcare, OptumRx. (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter and Prescriber Insights: Chart: Biologics and Inhalation Medications for AsthmaChart: Inhaled Medications for COPDIf you're not yet a Pharmacist's Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com. Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

COPD Champion Russell A. Acevedo, MD, FAARC, FCCP, FCCM, Honored with Jimmy A. Young Medal. Hear his story and learn more about what the award means to him!

Depression sufferers may have a new choice for treatment. C. Michael White, distinguished professor and chair of pharmacy practice at the University of Connecticut School of Pharmacy, explains. Michael White, Pharm.D., FCP, FCCP, FASHP has ~500 publications resulting in 18288 citations with an H-index of 70; placing him within an elite group of researchers. Dr. […]

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.HostJen Moulton, BSPharmPresident, CEimpactGuests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD,BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organismsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN: 0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.  The GameChangerThe new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.Guests Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthAmanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSAInfectious Disease PharmacistUnityPoint HealthTony Mannum, PharmDPGY2 Infectious Disease ResidentUnityPoint HealthReferenceIDSA Guidelines for treating resistant gram negative organisms Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.0.05 CEU/0.5 HrUAN:  0107-0000-24-251-H01-PInitial release date: 09/02/2024Expiration date: 09/02/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

CHEST September 2024, Volume 166, Issue 3 CHEST®  journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST September 2024 issue, including research into candidacy decision-making around venovenous extracorporeal membrane oxygenation, facilitators and barriers to developing state pandemic preparedness plans, and much more.

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.HostJen Moulton, BSPharmPresident, CEimpactGuest Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa ClinicReferenceGuidelinesPaperPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.  The GameChangerNew guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice. GuestGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthMatthew Trump, DO, FACP, FCCPPulmonologistThe Iowa Clinic ReferenceGuidelinesPaper Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).0.05 CEU/0.5 HrUAN: 0107-0000-24-247-H01-PInitial release date: 08/26/2024Expiration date: 08/26/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay its onset. The GameChangerSeveral studies suggest a delay in onset of dementia with the recombinant shingles vaccine.HostJen Moulton, BSPharmPresident, CEimpactGuest Geoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthReferenceThe recombinant shingles vaccine is associated with lower risk of dementiaPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe dementia's epidemiology and the significance of preventive interventions.2. Discuss the strengths, weaknesses, and outcomes of the study.0.05 CEU/0.5 HrUAN: 0107-0000-24-246-H01-PInitial release date: 08/19/2024Expiration date: 08/19/2025Additional CPE details can be found here.

Trial of the Week: PARAMEDIC2 Special Guest: Scott Benken, PharmD, MHPE, FCCP, FCCM, BCPS   06:20 – C4 conference preview 12:50 – PARAMEDIC2 trial of the week   C4 conference registration link: https://c4conference.uic.edu/ Reference list: https://pharmacytodose.com/wp-content/uploads/2024/08/paramedic2-tow-references.pdf 2024 Pharmacy to Dose Award nominations: https://forms.gle/BTgirsv8uoFj7Rux5   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

On the second August episode of JHLT: The Podcast, the Digital Media Editors discuss a paper from the August issue of JHLT, entitled “A modular simulation framework for organ allocation.”The episode is hosted by Digital Media Editor Erika Lease, MD, FCCP, a transplant pulmonologist from the University of Washington.   The guests for this episode are first author Johnie Rose, MD, PhD, of the Center for Community Health Integration at Case Western Reserve University School of Medicine, and lead author Maryam Valapour, MD, MPP, of the Department of Pulmonary Medicine at the Cleveland Clinic.   In the episode, Drs. Rose and Valapour share the findings from their study, and tackle questions about the limitations of simulation models, what makes their COMET model different from past Simulation Allocation Models (SAMs), and why they made the project open-source.   Follow along at www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

In part two of this discussion, Corinne Young, MSN, FNP‑C, FCCP, and Jessica Glennie, CNP, talk about the role of advanced practice providers in rural areas and how their role may differ from larger medical centers.

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings. The GameChangerAdopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management. HostJen Moulton, BSPharmPresident, CEimpactGuestsGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthJake Galdo, PharmD, MBA, BCPS, BCGPCEOSeguridadReferenceAtherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events EquationsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.0.05 CEU/0.5 HrUAN: 0107-0000-24-245-H01-PInitial release date: 08/12/2024Expiration date: 08/12/2025Additional CPE details can be found here.

Corinne Young, MSN, FNP‑C, FCCP, and Jessica Glennie, CNP, share insights on identifying, diagnosing, treating, and setting goals of care for patients with ILDs as advanced practice providers in a variety of practice settings (Part 1 of 2).

GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn't nearly enough content devoted to weighing all the variables associated with them, which  our experts aim to address.  In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime's four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value. Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University. Developing a holistic GLP-1 strategy Clinical Insights - Weight Management -- a holistic journey All Pharmacy Friends episodes

HRS-AKI & Terlipressin Special Guest: Stephanie Bass, PharmD, FCCP, BCPS, BCCCP   05:45 – HRS and HRS-AKI diagnosis 17:00 – Albumin and volume status 23:55 – Terlipressin/vasoconstrictor treatment 52:00 – Medication safety considerations   Reference List: https://pharmacytodose.com/wp-content/uploads/2024/07/hrsaki-terlipressin-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Trial of the Week: MENDS2 Special Guest: John Devlin, PharmD, BCCCP, MCCM, FCCP @devlinpharmd   03:20 – PADIS background and research introduction 35:25 – MENDS2 discussion   John Devlin joins to review the May Trial of the Week “Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis” the MENDS2 study, published in NEJM in 2021. We set the scene by discussing how John developed an interest with PADIS research, discussing PK/PD sedative properties and considerations, landmark trials prior to MENDS2, and how much background work is required for a large RCT. Then we dive into the MENDS2 trial itself. Any significant findings? Biggest methodologic differences from MENDS2 and previous studies? Most challenging process of blinding? Any potential safety concerns? How to avoid unblinding study patients (and why that's so important)? Plus, trial fun facts, seeing your name in a NEJM research article, applying MENDS2 findings into daily practice, and so much more.   Reference list: https://pharmacytodose.com/wp-content/uploads/2024/05/mends2-trial-of-the-week-references.pdf   PharmacyToDose.Com @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices